| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $111.8M | -38.6% |
| R&D Expense | $4.5M | +7.2% |
| SG&A Expense | $38.0M | -15.6% |
| Operating Income | -$187.7M | -2378.7% |
| Interest Expense | $5.7M | -19.9% |
| Pre-tax Income | -$206.7M | -3871.4% |
| Income Tax | $80K | +233.3% |
| Net Income | -$206.8M | -3854.7% |
| EPS (Basic) | -$23.00 | — |
| EPS (Diluted) | -$23.00 | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.1M | -79.9% |
| Accounts Receivable | $4.0M | +31.5% |
| Current Assets | $23.6M | -67.7% |
| Total Assets | $48.1M | -81.4% |
| Current Liabilities | $29.2M | -21.9% |
| Long-term Debt | $53.9M | -34.2% |
| Total Liabilities | $85.2M | -31.6% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.7M | -1126.7% |
| Capital Expenditures | $284K | -63.0% |
| Investing Cash Flow | -$7.7M | +79.7% |
| Financing Cash Flow | -$11.6M | -174.2% |
| Free Cash Flow | -$29.0M | -833.1% |
| Stockholders' Equity |
| -$37.1M |
| -127.6% |